Self-injurious behavior in neurodevelopmental disorders: Relevance of nociceptive and immune mechanisms

Neuroscience and Biobehavioral Reviews

Volumn 35, Issue 5, 2011, Pages 1266-1274

  Symons, Frank J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Developmental disorder; Immune; Pain; Self injury

Indexed keywords

BETA ENDORPHIN; BRAIN DERIVED NEUROTROPHIC FACTOR; DYNORPHIN; INTERLEUKIN 1; INTERLEUKIN 6; NERVE GROWTH FACTOR; SUBSTANCE P;

ALLODYNIA; APPETITE DISORDER; AUTISM; AUTOMUTILATION; CHRONIC PAIN; COGNITIVE DEFECT; CYTOKINE PRODUCTION; DEVELOPMENTAL DISORDER; HUMAN; HYPERALGESIA; IMMUNE SYSTEM; INFLAMMATION; INTELLECTUAL IMPAIRMENT; LANGUAGE DISABILITY; MAST CELL DEGRANULATION; MENTAL DEFICIENCY; NERVE CELL EXCITABILITY; NERVOUS SYSTEM INFLAMMATION; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; REINFORCEMENT; REVIEW; SENSORY DYSFUNCTION; SENSORY NEUROPATHY; SLEEP DISORDER; SOCIAL BEHAVIOR;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CHILD; DEVELOPMENTAL DISABILITIES; DISEASE MODELS, ANIMAL; HUMANS; MODELS, BIOLOGICAL; PAIN; PAIN THRESHOLD; SELF-INJURIOUS BEHAVIOR;

EID: 79952536516     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2011.01.002     Document Type: Review

References (98)

1. Albrecht P.J., Hines S., Eisenberg E., Pud D., Finaly D.R., Connolly M.K., Pare M., Davar G., Rice F.L. Pathologic alterations of cutaneous innervation and vasculature in affected limbs from patients with complex regional pain syndrome. Pain 2006, 120:244-266.
2. Arck P.C., Handjiski B., Peters E.M.J., Peter A.S., Hagen E., Fischer A., Klapp B.F., Paus R. Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollikular inflammatory events via neuropeptide substance-P dependent pathways. Am. J. Pathol. 2003, 162:803-814.
3. Ballard E., Bosk A., Pao M. Understanding brain mechanisms of pain processing in adolescents' non-suicidal self-injury. J. Youth Adol. 2010, 39:327-334.
4. Bartak L., Rutter M. Differences between mentally retarded and normally intelligent autistic children. J Aut. Child Schizo. 1976, 6:109-120.
5. Bodfish J.W., Symons F.J., Parker D.E., Lewis M.H. Varieties of repetitive behavior in autism: comparison to mental retardation. J. Aut. Dev. Dis. 2000, 30:237-243.
6. Bodfish J.W., Lewis M.H. Self-injury and comorbid behavior in developmental, neurological, psychiatric, and genetic disorders. Self-injurious Behavior: Gene-Brain-Behavior Relationships 2002, American Psychological Association Press, Washington, DC. S. Schroeder, M. Oster-Granite, T. Thompsons (Eds.).
7. Breese G.R., Criswell H.E., Duncan G.E., Moy S.S., Johnson K.B., Wong D.R., Mueller R.A. Model for reduced brain dopamine in Lesch-Nyhan Syndrome and the mentally retarded: neurobiology of neonatal-6-hydroxydopamine lesioned rats. Mentl. Retard. Dev. Dis. Res. Rev. 1995, 1:111-119.
8. Cabot P.J., et al. Immune cell-derived beta-endorphin. Production, release, and control of inflammatory pain in rats. J. Clin. Invest. 1997, 100:142-148.
9. Carr E.G. The motivation of self-injurious behavior: a review of some hypotheses. Psychol. Bull. 1977, 84:800-816.
10. Carr E.G., Newsom C.D., Binkoff J.A. Stimulus control of self-destructive behavior in a psychotic child. J. Abnorm. Child. Psychol. 1976, 4:139-153.
11. Caudle R.M., Mannes A.J. Dynorph: or foe?. Pain 2000, 87:235-239.
12. Coid J., Allolio B., Rees L.H. Raised plasma metenkaphlin in patients who habitually mutilate themselves. Lancet 1983, 545-546.
13. Cook E.H. Serotonergic mechanisms in self-injurious behavior and related disorders. Paper presented at NICHD Conference on SIB, December 6-7 1999.
14. Craig K.D., Prkachin K.M., Grunau R.V.E. The facial expression of pain. Handbook of Pain Assessment 1992, 257-276. Guilford Press, NY. D.C. Turk, R. Melzack (Eds.).
15. Dan Y., Mooney R.D. Sensory systems. Curr. Opin. Neurobiol. 2006, 16:359-362.
16. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Neurosci. 2008, 9:46-57.
17. Defrin R., Pick C.G., Peretz C., Carmeli E. A quantitative somatosensory testing of pain threshold in individuals with mental retardation. Pain 2004, 108:58-66.
18. Dines K.C., Powell H.C. Mast cell interactions with the nervous system: relationship to mechanisms of disease. J. Neuropathol. Exp. Neurol. 1997, 56:627-640.
19. Dou Y.C., Hagstromer L., Emtestam L., Johannson O. Increased nerve growth factor and its receptors in atopic dermatitis: an immunohistochemical study. Arch. Dermatol. Res. 2006, 296:31-37.
20. Drummond P.D. The effects of cutaneous mast cell degranulation on sensitivity to heat. Inflamm. Res. 2004, 53:309-315.
21. Eckman P., Friesen W.V. Investigator's guide to the Facial Action Coding System 1978, Consulting Psychologists Press, Palo Alto.
22. Elliot E., Ginzburg I. The role of neurotrophins and insulin on tau pathology in Alzheimer's disease. Rev. Neurosci. 2006, 17:635-642.
23. Ferry X., Brehin S., Kamel R., Landry Y. G protein-dependent activation of mast cells by peptides and basic secretagogues. Peptides 2002, 23:1507-1515.
24. Fisher W.W., Piazza C., Cataldo M., Harrell R., Jefferson G., Conner R. Functional communication training with and without extinction and punishment. J. Appl. Behav. Anal. 1993, 26:23-36.
25. Grunau R.V.E., Craig K.D. Facial activity as a measure of neonatal pain expression. Advances in Pain Research and Therapy 1990, vol. 15:147-156. Raven Press, NY.
26. Grunau R.V.E., Craig K.D. Pain expression in neonates: facial action and cry. Pain 1987, 28:395-410.
27. Haines J., Williams C.L., Brain K.L., Wilson G.V. The psychophysiology of self-mutilation. J. Abnorm. Psychol. 1995, 104:471-489.
28. Hall S.S., Arron K., Sloneem J., Oliver C. Health and sleep problems in Cornelia de Lange syndrome: g case control study. J. Int. Dis. Res. 2008, 52:458-468.
29. Hartman E.C., Gilles E., McComas J.J., Danov S.E., Symons F.J. Clinical observation of self-injurious behavior correlated with changes in scalp morphology in a child with congenital hydrocephalus. J. Child Neurol. 2008, 9:1062-1065.
30. Herman B.H., Hammock M.K., Arthur-Smith A., Egan J., Chatoor I., Wernes A., Zelnik N. Naltrexone decreases self-injurious behavior. Ann. Neurol. 1987, 22:550-552.
31. Herpertz S. Self-injurious behavior: psychopathological and nosological characteristics in subtypes of self-injurers. Acta Psychiatr. Scand. 1995, 91:57-68.
32. Iwata B.A., Dorsey M.F., Slifer K.J., Bauman K.E., Richman G.S. Toward a functional analysis of self-injury. Anal. Int. Dev. Dis. 1982, 2:3-20.
33. Iwata B.A., Pace G.M., Kissel R.C., Nau P.A., Farber J.M. The self-injury trauma (SIT) scale: a method for quantifying surface tissue damage caused by self-injurious behavior. J. Appl. Behav. Anal. 1990, 23:99-110.
34. Izard C.E., Huebner R.R., Risser D., McGinnes G.C., Dougherty L.M. The young infant's ability to produce discrete emotional expressions. Dev. Psychol. 1980, 16:132-140.
35. Kawana S., Liang Z., Nagano M., Suzuki H. Role of substance P in stress-derived degranulation of dermal mast cells in mice. J. Dermatol. Sci. 2006, 42:47-54.
36. Kennedy W.R., Wedelschafer-Crabb G., Johnson T. Quantification of epidermal nerves in diabetic neuropathy. Neurology. 1996, 47:1042-1048.
37. Kennedy W.R., Wendelschafer-Crabb G., Polydefkis M., McArthur J. Pathology and quantitation of cutaneous nerves. Peripheral Neuropathy 2005, 869-896. Saunders, Philadelphia. 4th ed. P.J. Dyck, P.K. Thomas (Eds.).
38. Kowalski J., Gabryel B., Labuzek K., Herman Z. Methionin-enkephalin and leucine-enkephalin increase interleukin-1beta release in mixed glia cultures. Neuropeptides 2002, 36:401-406.
39. Kowalski J., Makowiecka K., Belowski D., Herman Z.S. Augmenting effect of methionine-enkephalin on interleukin-6 production by cytokine-stimulated murine macrophages. Neuropeptides 2000, 34:187-192.
40. LaChapelle D.L., Hadjistavropoulos T., Craig K.D. Pain measurement in persons with intellectual disabilities. Clin. J. Pain 1999, 15:13-23.
41. Latremoliere A., Woolf C.J. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J. Pain 2009, 10:895-926.
42. Laughlin T.M., et al. Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors. Pain 1997, 72:253-260.
43. Lovaas I., Newsom C., Hickman C. Self-stimulatory behavior and perceptual reinforcement. J. Appl. Behav. Anal. 1987, 20:45-68.
44. Mace F.C., Lalli J.S., Shea M.C. Functional analysis of self-injury. Assessment, Analysis, and Treatment of Self-injury 1992, 122-152. Springer-Verlag, NY. J. Luiselli, J. Matson, N. Singh (Eds.).
45. Melzack R. Folk medicine and the sensory stimulation of pain. Textbook of Pain 1994, 1209-1217. Churchill Livingstone, New York. 3rd. ed. P.D. Wall, R. Melzack (Eds.).
46. Melzack R., Wall P.D. The Challenge of Pain 1983, Basic Books, Inc., NY.
47. Moalem G., Tracey D.J. Immune and inflammatory mechanisms in neuropathic pain. Brain Res. Rev. 2006, 51:240-264.
48. Moffitt T.E., Rutter M., Silva R.P. Sex Differences in Anti-social Behavior, Conduct Disorders, Delinquency, and Violence in the Dunedin Longitudinal Study 2001, Cambridge University Press, Cambridge, UK.
49. Mousa S.A., Shakibaei M., Sitte N., Schafer M., Stein C. Subcellular pathways of beta-endorphin synthesis, processing, and release from immunocytes in inflammatory pain. Endocrinology 2004, 145:1331-1341.
50. Nahin R.L., Hylden J.L., Iadarola M.J., Dubner R. Peripheral inflammation is associated with increased dynorphin immunoreactivity in both projection and local circuit neurons in the superficial dorsal horn of the rat lumbar spinal cord. Neurosci. Lett. 1989, 96:247-252.
51. National Institutes of Health 1991. Treatment of destructive behaviors in persons with developmental disabilities(NIH Publication No. 91-2410).
52. Naukkarinen A., Järvikallio A., Lakkakorpi J., Harvima I.T., Harvima R.J., Horsmanheimo M. Quantitative histochemical analysis of mast cells and sensory nerves in psoriatic skin. J. Pathol. 1996, 180:200-205.
53. Newell K.M., Challis J.H., Boros R.L., Bodfish J.W. Further evidence on the dynamics of self-injurious behaviors: impact forces and limb motions. Am. J. Ment. Retard. 2002, 107:60-68.
54. Nock M.K., Mendes W.B. Physiological arousal, distress tolerance, and social problem-solving deficits among adolescent self-injurers. J. Consult. Clin. Psychol. 2008, 76:28-128.
55. Novak M. Self-injurious behavior in rhesus monkeys: New insights into it etiology, physiology, and treatment. Am. J. Primatol. 2003, 59:3-19.
56. Nyhan W.L. Lessons from Lesch-Nyhan syndrome. Self-injurious Behavior: Gene-Brain-Behavior Relationships 2002, 251-267. American Psychological Association, Washington, DC. S.R. Schroeder, M.L. Oster-Granite, T. Thompson (Eds.).
57. Oberlander T.F., Gilbert C.A., Chambers C.T., O'Donnell M.E., Craig K.D. Biobehavioral responses to acute pain in adolescents with a significant neurologic impairment. Clin. J. Pain 1999, 15:201-209.
58. Oberlander T.F., Symons F.J., van Dongen K., Abu-Saad H.H. Pain in individuals with developmental disabilities: Challenges for the future. Proceedings of the 10th World Congress on Pain: Progress in Pain Research and Management 2003, 705-723. IASP Press, Seattle, WA. J.O. Dorstrovsky, D.B. Carr, M. Koltzenburg (Eds.).
59. O'Reilly M.F. Functional analysis of episodic self-injury correlated with recurrent otitis media. J. Appl. Behav. Anal. 1997, 30:165-167.
60. Ornitz E.M. The modulation of sensory input and motor output in autistic children. Psychopathology & Child Development 1976, 115-133. Plenum Press, New York. E. Schopler, R.J. Reichler (Eds.).
61. Paus R., Theoharides, Arck P.C. Neuroimmunoendocrine circuitry of the 'brain-skin connection'. Trends Immunol. 2006, 27:32-39.
62. Piva M., Moreno J.I., Jenkins F.S., Smith J.K., Thomas J.L., Montgomery C., Wilcons C.B., Sizemore R.C. In vitro modulation of cytokine expression by enkephalin-derived peptides. Neuroimmunomodulation 2005, 12:339-347.
63. Rice F.L., Albers K.M., Davis B.M., Silos-Santiago I., Wilkinson G.A., LeMaster A.M., Ernfors P., Smeyne R.J., Aldskogius H., Phillips H.S., Barbacid M., DeChiara T.M., Yancopoulos G.D., Dunne C.E., Fundin B.T. Differential dependency of unmyelinated and A delta epidermal and upper dermal innervation on neurotrophics, trk receptors, and p75LNGFR. Dev. Biol. 1998, 198:57-81.
64. Roach E.S., Abramson J.S., Lawless M.R. Self-injurious behavior in acquired sensory neuropathy. Neuropediatrics 1985, 16:159-161.
65. Rojahn J., Schroeder S.R., Hoch T.A. Self-injurious Behavior in Intellectual Disabilities 2008, Elsevier Ltd, Oxford, UK.
66. Russ M.J., Roth S.D., Lerman A., Kakuma T., Harrison K., Shindledecker R.D., Hull J., Mattis S. Pain perception in self-injurious patients with borderline personality disorder. Biol. Psychiatry 1992, 32:501-511.
67. Sandman C.A. Beta-endorphin dysregulation in autistic and self-injurious behavior: a neurodevelopmental hypothesis. Synapse 1988, 2:193-199.
68. Sandman C.A. The opiate hypothesis in autism and self-injury. J. Child Adolesc. Psychopharmacol. 1990/1991, 1:237-248.
69. Sandman C.A., Spence M.A., Smith M. Proopiomelanocortin (POMC) disregulation and response to opiate blockers. Ment. Retard. Dev. Dis. Res. Rev. 1999, 5:314-321.
70. Sandman C.A., Touchette P.E., Marion S.D., Chicz-DeMet A. The role of proopiomelanocortin (POMC) in sequentially dependent self-injurious behavior. Dev. Psychobiol. 2008, 50:680-689.
71. Schroeder S.R., Oster-Granite M.L., Berkson G., Bodfish J.W., Breese G.R., Cataldo M.F., Cook E.H., Crnic L.S., DeLeon I., Fisher W., Harris J.C., Horner R.H., Iwata B., Jinnah H.A., King B.H., Lauder J.M., Lewis M.H., Kewell K., Nyhan W.L., Rojahn J., Sackett G.P., Sandman C., Symons F.J., Tessel R.E., Thompson T., Wong D.F. Self-injurious behavior: Gene-Brain-Behavior Relationships. Ment. Retard. Dev. Dis. Res. Rev. 2001, 7:3-12.
72. Singh L.K., Pang X., Alexacos N., Letourneau R., Theoharides T.C. Acute immobilization stress triggers skin mast cell degranulation via cotricotropin releasing hormone, neurotensin, and substance P: a link to neurogenic skin disorders. Brain Behav. Immun. 1999, 13:225-239.
73. Symons F.J. Pain and self-injury: mechanisms and models. Self-injurious Behavior: Genes, Brain, and Behavior 2002, American Psychological Association. S. Schroeder, T. Thompson, M.L. Oster-Granite (Eds.).
74. Symons F.J., Butler M.G., Sanders M.D., Feurer I.D., Thompson T. Self-injurious behavior and Prader-Willi syndrome: behavioral forms and body locations. Am. J. Ment. Retard. 1999, 104:260-269.
75. Symons F.J., Clark R.D., Hatton D.D., Skinner M., Bailey D.B. Self-injurious behavior in young boys with fragile X syndrome. Am. J. Med. Gen. 2003, 118:115-121.
76. Symons F.J., Fox N.D., Thompson T. Functional communication training and naltrexone treatment of self-injurious behavior: an experimental case report. J. Appl. Res. Int. Dis. 1998, 11:273-292.
77. Symons F.J., Harper V.H., Breau L., McGrath P.J., Bodfish J.W. Evidence of increased non-verbal behavioral signs of pain in adults with neurodevelopmental disorders and chronic self-injury. Res. Dev. Dis. 2009, 30:521-528.
78. Symons F.J., Sutton K.A., Bodfish J.W. A preliminary study of altered skin temperature at body sites associated with self-injurious behavior in adults with developmental disabilities. Am. J. Ment. Retard. 2001, 106:336-343.
79. Symons F.J., Sutton K.A., Walker C., Bodfish J.W. Altered diurnal pattern of salivary substance-P in adults with developmental disabilities and chronic self-injury. Am. J. Ment. Retard. 2003, 108:13-18.
80. Symons F.J., Tapp J., Wulfsberg A., Sutton K.A., Heeth W.L., Bodfish J.W. Sequential analysis of the effects of naltrexone on the environmental mediation of self-injurious behavior. Exp. Clin. Psychopharmacol. 2001, 9:269-276.
81. Symons F.J., Shinde S., Clary J., Harper V., Bodfish J.W. A sham-controlled sensory testing protocol for nonverbal individuals with intellectual and developmental disabilities: self-injury and gender effects. J. Pain 2010, 11:773-781.
82. Symons F.J., Thompson T. Self-injurious behavior and body site preference. J. Int. Dis. Res. 1997, 41:456-468.
83. Symons F.J., Wendelschafer-Crabb G., Kennedy W., Hardrict R., Dahl N., Bodfish J.W. Evidence of altered epidermal nerve fiber morphology in adults with self-injurious behavior and neurodevelopmental disorders. Pain 2008, 134:232-237.
84. Symons F.J., Wendelschafer-Crabb G., Kennedy W., Heeth W., Bodfish J.W. Degranulated mast cells in the skin of adults with self-injurious behavior and neurodevelopmental disorders. Brain Behav. Immun. 2009, 23:365-370.
85. Suzuki R., Furuno T., McKay D.M., Wolvers D., Teshima R., Nakanishi M., Bienenstock J. Direct neurite-mast cell communication in vitro occurs via the neuropeptide substance P. J. Immunol. 1999, 163:2410-2415.
86. Thompson T., Hackenberg T., Cerutti D., Baker D., Axtell S. Opioid antagonist effects on self-injury in adults with mental retardation: response form and location as determinants of medication effects. Am. J. Ment. Retard. 1994, 99:85-102.
87. Thompson, T., Schroeder, S.R. (Eds.), 1995. Self-injury in developmental disabilities: neurobiological and environmental mechanisms. Ment. Retard. Dev. Dis. Res. Rev., 1.
88. Thorn S.A., Herrero J.F. Headley PM Stimulus intensity and the comparative efficacy of mu- and kappa-opioid agonists on nociceptive spinal reflexes in the rat. Brain Res. 1994, 663:352-356.
89. Vanderah T.W., et al. Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. J. Neurosci. 2000, 20:7074-7079.
90. Watkins L.R., Wiertelak E.P., Grisel J.E., Silbert L.H., Maier S.F. Parallel activation of multiple spinal opiate systems appears to mediate 'non-opiate' stress-induced analgesias. Brain Res. 1992, 594:99-108.
91. Watkins L.R., Maier S.F. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol. Rev. 2002, 82:981-1101.
92. Watkins L.R., Maier S.F., Goehler L.E. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses, and pathological pain states. Pain 1995, 63:289-302.
93. Textbook of Pain 1994, Churchill Livingstone, New York. 3rd. ed. P.D. Wall, R. Melzack (Eds.).
94. Westbrook R.F., Greeley J.D. Some effects of the opioid antagonist, naloxone, upon the rat's reactions to a heat stressor. Q. J. Exp. Psychol. B 1990, 42:1-40.
95. Woolf C.J. The pathophysiology of peripheral neuropathic pain-abnormal peripheral input and abnormal central processing. Acta Neurochir. Suppl. (Wien) 1993, 58:125-130.
96. Woolf C.J. Dissecting out mechanisms responsible for peripheral neuropathic pain: implications for diagnosis and therapy. Life Sci. 2004, 74:2605-2610.
97. Yamaoka J., Di Z.H., Sun W., Kawana S. Changes in cutaneous sensory nerve fibers induced by skin scratching in mice. J. Dermatol. Sci. 2007, 46:41-51.
98. Zuo Y., Perkins N.M., Tracey D.J., Geczy C.L. Inflammation and hyperalgesia induced by nerve injury in the rat: a key role of mast cells. Pain 2003, 105:467-479.